Abstract

9030 Background: Kaposi's sarcoma (KS) continuous being a frequent neoplasm in third world AIDS patients. Liposomal doxorubicin (LD) is the drug of choice for advanced KS; nevertheless, it is very ...

Full Text

Published Version

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Gastrointestinal and cutaneous AIDS-related Kaposi's sarcoma: Different activity of liposomal doxorubicin according to location of lesions
D E Hernandez-Morales ... A E Hernàndez-Zaccaro
Journal of Clinical Oncology | VOL. 22
D E Hernandez-Morales, et. al.D E Hernandez-Morales ... A E Hernàndez-Zaccaro
15 Jul 2004
Gastrointestinal and cutaneous AIDS-related Kaposi's sarcoma: different activity of liposomal doxorubicin according to location of lesions
D.E Hernandez-Morales ... A.E Hernandez-Zaccaro
European Journal of Cancer Care | VOL. 14
D.E Hernandez-Morales, et. al.D.E Hernandez-Morales ... A.E Hernandez-Zaccaro
08 Jun 2005
Immune reconstitution inflammatory syndrome associated with acquired immunodeficiency syndrome-related gastrointestinal limited Kaposi's sarcoma presenting as acute intestinal obstruction: a case report
Jyotirmoy Pal ... Ankit Shrivastav
Journal of Medical Case Reports | VOL. 5
Jyotirmoy Pal, et. al.Jyotirmoy Pal ... Ankit Shrivastav
26 Jul 2011
British HIV Association guidelines for HIV‐associated malignancies 2008
M Bower ... A Webb
HIV Medicine | VOL. 9
M Bower, et. al.M Bower ... A Webb
01 Jul 2008
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Influence of Nucleophosmin ( NPM1 ) Genotypes on Outcome of Patients With AML: An AIEOP-BFM and COG-SWOG Intergroup Collaboration
Claudia Tregnago ... Martina Pigazzi
Journal of Clinical Oncology | VOL. -
Claudia Tregnago, et. al.Claudia Tregnago ... Martina Pigazzi
02 Dec 2024
Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor–Positive, Node-Positive Breast Cancer
Lajos Pusztai ... Kevin M Kalinsky
Journal of Clinical Oncology | VOL. -
Lajos Pusztai, et. al.Lajos Pusztai ... Kevin M Kalinsky
02 Dec 2024
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O 6 -Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET)
Thomas Walter ...
Journal of Clinical Oncology | VOL. -
Thomas Walter, et. al.Thomas Walter ...
25 Nov 2024
Using Cure Models for Trial Analysis and Design
Michael L Leblanc
Journal of Clinical Oncology | VOL. -
Michael L LeblancMichael L Leblanc
25 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.